AdaptVac ApS
Private limited companyCVR 38732730FrederiksbergActive
AdaptVac ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2017. The company went from a profit in 2024 to a loss of DKK 7.1m in 2025. Equity fell to DKK 10.8m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 138% (2024 → 2025), to −DKK 3.2m.
- Net profit went from a profit of DKK 1.7m to a loss of DKK 7.1m (2024 → 2025).
- Equity fell 39% (2024 → 2025), to DKK 10.8m.
Employees
- 1 fewer employees than a year earlier: 8 (07/2026) against 9 (07/2025).
Management and owners, last 24 months
- New in management: Martin Roland Jensen (board member, 10/06/2026).
- Stepped down: Allan Rosetzsky (board member, 10/06/2026).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 20,231 | 1,331 | −1,582 | 69,205 | 8,393 | −3,161 | −137.7% |
| Operating profit (EBIT) | – | −2,022 | −5,802 | 64,035 | 2,944 | −9,147 | −410.7% |
| Profit before tax | 18,715 | −2,283 | −5,884 | 64,047 | 2,145 | −9,037 | −521.4% |
| Net profit | 15,460 | −1,782 | −4,795 | 50,886 | 1,714 | −7,054 | −511.4% |
| Total assets | 38,630 | 15,194 | 14,015 | 98,167 | 20,036 | 22,976 | +14.7% |
| Equity | 15,339 | 12,557 | 7,762 | 58,648 | 17,862 | 10,809 | −39.5% |
| Liabilities | 23,291 | 2,637 | 6,253 | 39,518 | 2,174 | 12,167 | +459.7% |
| Cash and cash equivalents | 30,521 | 11,942 | 9,104 | 2,778 | 14,953 | 9,495 | −36.5% |
| Average number of employees | 3 | 5 | 6 | 6 | 6 | 7 | +16.7% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresEquity fell sharply
Equity fell 39% from 2024 to 2025 (DKK 17.9m to DKK 10.8m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 12/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 30/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 14/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 17/05/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 26/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 28/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,385of 69,742 Better than 1% | No. 8,609of 69,964 Better than 88% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 282of 323 Better than 13% | No. 62of 329 Better than 81% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,369of 33,588 Better than 1% | No. 3,544of 33,687 Better than 89% |
| All companies of type ApS66,508 companies in the comparison | No. 66,077of 66,379 Better than 0% | No. 6,496of 66,505 Better than 90% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- AdaptVac ApS−DKK 3.2m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- AdaptVac ApS−DKK 7.1m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- AdaptVac ApSDKK 10.8m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- AdaptVac ApS8
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- NextGen Vaccines Holding ApS50%
- Expres2ion Biotechnologies ApS33.33%
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Adam Frederik Sander Bertelsen | Director | 22/06/2017 |
| Willem Adriaan De Jongh | CEO | 02/10/2017 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Ali El-Salanti | Board member | 02/10/2017 |
| Adam Frederik Sander Bertelsen | Board member | 02/10/2017 |
| Morten Agertoug Nielsen | Chair of the board | 06/01/2020 |
| Jacob Hjulmand | Board member | 27/05/2021 |
| Martin Roland Jensen | Board member | 10/06/2026 |
- Founders
- Expres2ion Biotechnologies ApS, NextGen Vaccines Holding ApS
Former management (6)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Willem Adriaan De Jongh | Director | 22/06/2017 | 01/10/2017 |
| Bent Ulrich Frandsen | Board member | 02/10/2017 | 27/05/2021 |
| Willem Adriaan De Jongh | Board member | 02/10/2017 | 26/02/2020 |
| Steen Søren Klysner | Chair of the board | 02/10/2017 | 06/01/2020 |
| Morten Agertoug Nielsen | Board member | 02/10/2017 | 05/01/2020 |
| Allan Rosetzsky | Board member | 06/01/2020 | 10/06/2026 |
Signing rule: Selskabet tegnes af den administrerende direktør og en direktør i forening eller af 4 medlemmer af bestyrelsen i forening.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| AdaptVac ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 9 | 1022555258 |
Purpose
Virksomhedens formål er at udvikle produkter og teknologi indenfor området vacciner og immunterapi samt hermed efter ledelsens skøn beslægtet virksomhed og serviceydelser.
The purpose is quoted from the register in Danish.
Changes year by year
34 registered events20263 changesaccounts 1 · management 2
- AccountsAnnual report for 2025 published
- ManagementMartin Roland Jensen appointed board member
- ManagementAllan Rosetzsky stepped down as board member
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesaccounts 1 · address 1
- AccountsAnnual report for 2023 published
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20222 changesaccounts 1 · address 1
- AccountsAnnual report for 2021 published
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
20215 changesaccounts 1 · management 2 · ownership 2
- AccountsAnnual report for 2020 published
- ManagementJacob Hjulmand appointed board member
- ManagementBent Ulrich Frandsen stepped down as board member
- OwnershipEXPRES2ION BIOTECHNOLOGIES ApS registered as owner (33.33%)
- OwnershipEXPRES2ION BIOTECHNOLOGIES ApS is no longer registered as owner
20205 changesmanagement 5
- ManagementWillem Adriaan De Jongh stepped down as board member
- ManagementMorten Agertoug Nielsen appointed chair of the board
- ManagementAllan Rosetzsky appointed board member
- ManagementSteen Søren Klysner stepped down as chair of the board
- ManagementMorten Agertoug Nielsen stepped down as board member
201714 changesaddress 1 · management 10 · founded 1 · ownership 2
- AddressMoved to Agern Alle 1, 2970 Hørsholm
- ManagementMorten Agertoug Nielsen appointed board member
- ManagementWillem Adriaan De Jongh appointed board member
- ManagementBent Ulrich Frandsen appointed board member
- ManagementWillem Adriaan De Jongh appointed ceo
- ManagementAli El-Salanti appointed board member
- ManagementAdam Frederik Sander Bertelsen appointed board member
- ManagementSteen Søren Klysner appointed chair of the board
- ManagementWillem Adriaan De Jongh stepped down as director
- FoundedRegistered as AdaptVac ApS
- ManagementAdam Frederik Sander Bertelsen appointed director
- ManagementWillem Adriaan De Jongh appointed director
- OwnershipEXPRES2ION BIOTECHNOLOGIES ApS registered as owner (50%)
- OwnershipNextGen Vaccines Holding ApS registered as owner (50%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Klifo A/Svia Allan Rosetzsky
- Minervax ApSvia Steen Søren Klysner
- Expres2ion Biotechnologies ApSvia Allan Rosetzsky
- Zyneyro ApSvia Steen Søren Klysner
- Var2 Pharmaceuticals ApSvia Ali El-Salanti
- VarCT Diagnostics ApSvia Ali El-Salanti
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.